INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2016

Curcumin supplementation prevented a 6-month cognitive decline seen with placebo, but showed no other differences across cognitive tests in older adults.

A 12-month randomized, placebo-controlled, double-blind study evaluated the effect of 1500 mg/d BiocurcumaxTM versus placebo in 96 community-dwelling older adults. A significant time×treatment interaction was detected for the Montreal Cognitive Assessment (F=3.85, P<0.05), driven by a decline in function in the placebo group at 6 months that was not seen in the curcumin group. No differences between the groups were observed for all other clinical and cognitive measures.

Study type
12-month randomized, placebo-controlled, double-blind trial
Who was studied
96 community-dwelling older adults
What was measured
Cognitive and clinical measures assessed at baseline, 6 months, and 12 months

THE PAPER

Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults.

Rainey-Smith SR, Brown BM, Sohrabi HR, Shah T, Goozee KG, Gupta VB, Martins RN. Br J Nutr, 2016.

PubMed 27102361 ↗DOI 10.1017/s0007114516001203 ↗

Brain & moodHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.